A combination treatment with a water extract from Euglena gracilis and anti-PD-1 antibody strongly inhibits growth of lung cancer in mice through stimulating tumor-infiltrating lymphocytes
Authors:
- 13 January 2025
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 147, 113953
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (P20 GM103418)
- Kansas State University
- College of Veterinary Medicine, Kansas State University
- Johnson Cancer Research Center, Kansas State University (P20 GM103418)
This publication has 47 references indexed in Scilit:
- Short-Chain Fatty Acid (SCFA) as a Connecting Link between Microbiota and Gut-Lung Axis─A Potential Therapeutic Intervention to Improve Lung HealthACS Omega, 2024
- Water extract from Euglena gracilis prevents lung carcinoma growth in mice by attenuation of the myeloid-derived cell populationBiomedicine & Pharmacotherapy, 2020
- Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancerCancer Letters, 2019
- Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)Advances in Therapy, 2019
- The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune checkpoint inhibitorsInternational Journal of Cancer, 2019
- Oral administration of Euglena gracilis Z and its carbohydrate storage substance provides survival protection against influenza virus infection in miceBiochemical and Biophysical Research Communications, 2017
- Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in MicePharmaceutical Research, 2016
- The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in MelanomaClinical Therapeutics, 2015
- Expression and function of PD‐1 in human γδ T cells that recognize phosphoantigensEuropean Journal of Immunology, 2010
- Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumoursCancer Immunology, Immunotherapy, 1997